nifedipine has been researched along with enalaprilat anhydrous in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (23.53) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Appenheimer, M; Düsing, R; Graack, GH; Ko, YD; Sachinidis, A; Vetter, H; Wieczorek, AJ | 1 |
Adkins, E; Emmert, S; Ludden, CT; Ribeiro, LG; Seymour, AA; Sweet, CS | 1 |
Bidiville, J; Brunner, HR; Nussberger, J; Porchet, M; Waeber, B; Waeber, G | 1 |
Atlas, SA; Case, DB; Cody, RJ; Laragh, JH | 1 |
Cody, RJ | 1 |
Mehring, N; Neusser, M; Tepel, M; Zhu, Z; Zidek, W | 1 |
Bur, A; Herkner, H; Hirschl, MM; Kürkciyan, I; Laggner, AN; Müllner, M; Seidler, D | 1 |
Marik, PE; Varon, J | 1 |
Friberg, P; Nilsson, AB | 1 |
Broscious, R; Devabhakthuni, S; Noel, ZR; Watson, K | 1 |
4 review(s) available for nifedipine and enalaprilat anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Angiotensin II-mediated vasoconstriction in chronic congestive heart failure, and response to converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Enalapril; Enalaprilat; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Nifedipine; Renin; Renin-Angiotensin System; Vasoconstriction | 1984 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
Focused Update on Pharmacologic Management of Hypertensive Emergencies.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Emergencies; Enalaprilat; Female; Guideline Adherence; Heart Failure; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Intracranial Hemorrhages; Labetalol; Nifedipine; Pre-Eclampsia; Pregnancy; Pyridines; Stroke | 2018 |
1 trial(s) available for nifedipine and enalaprilat anhydrous
Article | Year |
---|---|
Individual responses to converting enzyme inhibitors and calcium antagonists.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Enalapril; Enalaprilat; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation; Time Factors | 1988 |
12 other study(ies) available for nifedipine and enalaprilat anhydrous
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Cell Division; Cells, Cultured; Diltiazem; DNA Replication; Dose-Response Relationship, Drug; Enalaprilat; Female; Metoprolol; Muscle, Smooth, Vascular; Nifedipine; Platelet-Derived Growth Factor; Rats; Rats, Inbred WKY | 1992 |
Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Dogs; Drug Therapy, Combination; Enalapril; Enalaprilat; Felodipine; Heart; Heart Failure; Hypertension; Lisinopril; Male; Nifedipine; Nitrendipine; Rats; Rats, Inbred SHR | 1986 |
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Captopril; Enalapril; Enalaprilat; Heart Failure; Humans; Hypertension; Kinetics; Male; Nifedipine; Renin; Renin-Angiotensin System; Sodium; Teprotide; Vascular Resistance | 1983 |
Effect of captopril on vasoconstriction and Ca2+ fluxes in aortic smooth muscle.
Topics: Analysis of Variance; Angiotensin II; Animals; Aorta, Thoracic; Bradykinin; Calcium; Calcium Channels; Captopril; Cells, Cultured; Culture Techniques; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Enalaprilat; Hypertension; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vasoconstriction | 1993 |
Efficacy of different antihypertensive drugs in the emergency department.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Emergency Medical Services; Enalaprilat; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Piperazines; Treatment Outcome | 1996 |
Acute renal responses to angiotensin-converting enzyme inhibition in the neonatal pig.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blood Pressure; Calcium Channel Blockers; Enalaprilat; Enzyme Inhibitors; Extracellular Space; Hemodynamics; Hydrostatic Pressure; Injections, Intravenous; Kidney; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide Synthase; Reference Values; Renal Circulation; Swine; Time Factors | 2000 |